Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rader

Showing results (91-100 of 1,023) with videos related to

Pageof 103
Sort By:
Current Cardiovascular Risk Reports|August 20, 2011
Clinical Implications of Lipid Genetics for Cardiovascular DiseaseAlanna Strong, Daniel J Rader
Circulation Research|May 29, 2000
Genetic susceptibility to atherosclerosis: insights from miceD J Rader, E Puré
Nature Reviews. Cardiology|June 3, 2009
Update on strategies to increase HDL quantity and functionDanielle Duffy, Daniel J Rader
The Medical Clinics of North America|February 24, 2000
Management of selected lipid abnormalities. Hypertriglyceridemia, low HDL cholesterol, lipoprotein(a), in thyroid and renal diseases, and post-transplantationD J Rader, S Rosas
Current Opinion in Lipidology|April 29, 2000
Endothelial lipase: a new member of the triglyceride lipase gene familyD J Rader, M Jaye
Clinical Pharmacology and Therapeutics|April 10, 2014
High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigmS Tuteja, D J Rader
Journal of the American College of Cardiology|July 27, 2019
Polygenic Risk Scores in Familial HypercholesterolemiaDaniel J Rader, Samip Sheth
Lancet (London, England)|April 9, 2013
Lipid-lowering treatment for homozygous familial hypercholesterolaemia--authors' replyMarina Cuchel, Daniel J Rader
Circulation Research|December 7, 2013
High-density lipoprotein: NO failure in heart failureAli Javaheri, Daniel J Rader
Journal of the American College of Cardiology|May 3, 2023
Lipoprotein(a) and Oxidized Phospholipids: Partners in Crime or Individual Perpetrators in Cardiovascular Disease?Daniel J Rader, Archna Bajaj
Pageof 103

Showing results (91-100 of 1,023) with videos related to

Sort By:
Pageof 103
Current Cardiovascular Risk Reports|August 20, 2011
Clinical Implications of Lipid Genetics for Cardiovascular DiseaseAlanna Strong, Daniel J Rader
Circulation Research|May 29, 2000
Genetic susceptibility to atherosclerosis: insights from miceD J Rader, E Puré
Nature Reviews. Cardiology|June 3, 2009
Update on strategies to increase HDL quantity and functionDanielle Duffy, Daniel J Rader
The Medical Clinics of North America|February 24, 2000
Management of selected lipid abnormalities. Hypertriglyceridemia, low HDL cholesterol, lipoprotein(a), in thyroid and renal diseases, and post-transplantationD J Rader, S Rosas
Current Opinion in Lipidology|April 29, 2000
Endothelial lipase: a new member of the triglyceride lipase gene familyD J Rader, M Jaye
Clinical Pharmacology and Therapeutics|April 10, 2014
High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigmS Tuteja, D J Rader
Journal of the American College of Cardiology|July 27, 2019
Polygenic Risk Scores in Familial HypercholesterolemiaDaniel J Rader, Samip Sheth
Lancet (London, England)|April 9, 2013
Lipid-lowering treatment for homozygous familial hypercholesterolaemia--authors' replyMarina Cuchel, Daniel J Rader
Circulation Research|December 7, 2013
High-density lipoprotein: NO failure in heart failureAli Javaheri, Daniel J Rader
Journal of the American College of Cardiology|May 3, 2023
Lipoprotein(a) and Oxidized Phospholipids: Partners in Crime or Individual Perpetrators in Cardiovascular Disease?Daniel J Rader, Archna Bajaj
Pageof 103